Find real-time MRNA - Moderna Inc stock quotes company profile news and forecasts from CNN Business. Based on careful and fact-backed analyses by Wall Street experts the current consensus on the target price for MRNA shares is 14592 per share.
Moderna Mrna Stock Gets Higher Goldman Price Target On Vaccine Bloomberg
MRNA stock quote history news and other vital information to help you with your stock trading and investing.
Mrna price target. MRNA stock forecast and price target. Based on careful and fact-backed analyses by Wall Street experts the current consensus on the target price for MRNA shares is 17425 per share. Mar 16 2021 1102AM EDT.
Analysis on target price and performance of stocks is usually carefully studied by market experts and the current Wall Street consensus on MRNA stock is a recommendation set at 260. Over the past 12 months Modernas MRNA share price has increased by a spectacular 517. I n recent trading shares of Moderna Inc Symbol.
160 rows 16 Wall Street analysts have set twelve-month price targets for Moderna in the last year. Their average twelve-month price target is 16244 predicting that the stock has a possible upside of 125. Based on our forecasts a long-term increase is expected the MRNA stock price prognosis for 2026-04-24 is 399741 USD.
MRNA Moderna Inc. BMO Capital analyst George Farmer raised the firms price target on Moderna to 112 from 83 and keeps an Outperform rating on the shares. AT CLOSE 400 PM EDT 051421.
MRNA Broker Recommendations Summary The Trend in the Broker Recommendations. MRNA analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Average Target Price.
The Goldman Sachs Groups target price would suggest a potential upside of 4933 from the stocks previous close. AFTER HOURS 759 PM EDT 051421. Moderna NASDAQMRNA had its target price increased by The Goldman Sachs Group from 20600 to 22800 in a research report released on.
The high price target for MRNA is 23100 and the low price target for MRNA is 8000. At the outset of 2020 Moderna MRNA was hardly a household name. The companys interim results from NIAIDs Phase 1 trial evaluating mRNA-1273 as a COVID-19 vaccine has meaningfully reduced clinical risk and should continue to generate investor interest in the program the analyst tells investors in a research.
According to 14 Wall Street analysts that have issued a 1 year MRNA price target the average MRNA price target is 15593 with the highest MRNA stock price forecast at 23400 and the lowest MRNA stock price forecast at 6800. Find the latest Moderna Inc. Your current 100 investment may be up to 22354 in 2026.
Find the latest Moderna Inc. Moderna NASDAQMRNA Price Target and Consensus Rating 17 Wall Street analysts have issued ratings and price targets for Moderna in the last 12 months. Based on analysts offering 12 month price targets for MRNA in the last 3 months.
Analysis on target price and performance of stocks is usually carefully studied by market experts and the current Wall Street consensus on MRNA stock is a recommendation set at 250. With a 5-year investment the revenue is expected to be around 12354. Analyst Estimates Rating WSJ.
What is MRNAs Price Target. MRNA have crossed above the average analyst 12-month target price of 14331 changing hands for. Moderna NASDAQMRNA had its price target increased by research analysts at The Goldman Sachs Group from 20600 to 22800 in a report issued on Thursday Benzinga reports.
The firm currently has a buy rating on the stock. The average price target is 000 with a high estimate of 000 and a low estimate of 000. Over the past 168 days MRNAs average price target has gone up 6843.
Analyst Boosts Price Target. Marty Shtrubel Jan 19 2021. Over the past 265 days MRNAs average upside potential has been 1947.